• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    4.21 Down 0.08(1.86%) Feb 5, 4:00PM EST
    Prev Close:4.29
    Open:4.24
    Bid:4.06 x 400
    Ask:N/A
    1y Target Est:11.50
    Beta:3.48
    Next Earnings Date:N/A
    Day's Range:4.14 - 4.37
    52wk Range:3.74 - 11.15
    Volume:1,062,930
    Avg Vol (3m):993,323
    Market Cap:293.88M
    P/E (ttm):N/A
    EPS (ttm):-0.64
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PGNX

    Comparison

    Symbol% ChgMkt Cap
    PGNXDown 1.86%293.88M
    NKTRUp 2.14%1.59B

    Key Statistics

    Forward P/E (1 yr):15.59
    P/S (ttm):99.49
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.60
    Quarterly EPS Est (Dec-15) :-0.14
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):-0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. The company’s primary clinical-stage product candidates include prostate specific membrane antigen (PSMA) antibody-drug conjugate, which... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback